ClearPoint Neuro, Inc. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
ClearPoint Neuro, Inc. (CLPT) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2025-02-26
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2024-12-31 was $0.00.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2024-09-30 was $0.00.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2023-09-30 was $0.00.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2023 was $10.00M, a 16.67% decline from fiscal 2022.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2022 was $12.00M.
- ClearPoint Neuro, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2021 was $0.00.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $10.00M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $10.00M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $10.00M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $12.00M derived: sum of 2 quarters · filed 2024-03-12 | $12.00M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |